DUBLIN--(BUSINESS WIRE)--Jun 14, 2018--The "Paper Diagnostics - Global Market Outlook (2017-2023)" report has been added to ResearchAndMarkets.com's offering.

The Global Paper Diagnostics market is accounted for $4.44 billion in 2016 and is expected to reach $9.28 billion by 2023 growing at a CAGR of 11.11%.

The rise in the prevalence of diabetes, low cost of production, growing demand for cost-efficient alternatives coupled with technological advancements, the increasing prevalence of liver disorders, the high reliability of paper diagnostics and rising geriatric population are some the key factors fueling the market growth.

Lateral flow assay kits are the largest contributors to the paper diagnostics market. The presence of diseases that require self-monitoring, for instance in diabetes mellitus, and other tests such as pregnancy test, pH test, oxygen sensing; and rising demand for cost effective devices made by technological advancements are the other major factors for paper diagnostics market growth.

The growing incidence rate of infectious diseases such as cancer, human immunodeficiency virus (HIV), and lifestyle-associated disorders such as diabetes and pre-diabetes is responsible for the increasing sales of paper diagnostics in hospitals. The market will continue to grow in the hospital segment for the upcoming years due to the bulk purchase of diagnostic kits, dipsticks, and other consumables.

Segments Covered

Products

Dipsticks Lateral flow assay kits

Applications

Food Quality Testing Environmental Monitoring Clinical Diagnostics

Device Types

Diagnostics Devices Monitoring Devices

End-Users

Home Healthcare Hospitals Biotech-Pharma Research Other End Users

Key Topics Covered

1 Executive Summary

2 Preface

3 Market Trend Analysis

4 Porters Five Force Analysis

5 Global Paper Diagnostics Market, By Product

6 Global Paper Diagnostics Market, By Application

7 Global Paper Diagnostics Market, By Device Type

8 Global Paper Diagnostics Market, By End-User

9 Global Paper Diagnostics Market, By Geography

10 Key Developments

11 Company Profiling

ARKRAY ACON Laboratories Abingdon Health Abcam Alere Bio-Rad Laboratories Siemens Healthcare Surmodics Sigma-Aldrich (Merck Millipore) SD Biosensor NanoHybrids Innova Biosciences DCN Diagnostics Cytodiagnostics Chembio Diagnostic Systems BIOPORTO BBI Solutions

For more information about this report visit https://www.researchandmarkets.com/research/7ljr4b/global_paper?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180614005517/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Diagnostics,Pulp and Paper

KEYWORD:

INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES MEDICAL SUPPLIES

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 06/14/2018 07:37 AM/DISC: 06/14/2018 07:36 AM

http://www.businesswire.com/news/home/20180614005517/en